Carolin Schwehm
Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase-4 (DPP-4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol-3 Kinase δ (PI3Kδ) inhibitors
Schwehm, Carolin; Kellam, Barrie; Garces, Aimie; Hill, Stephen J.; Kindon, Nicholas; Bradshaw, Tracey D.; Li, Jin; Macdonald, Simon J.F.; Rowedder, James E.; Stoddart, Leigh A.; Stocks, Michael
Authors
Professor BARRIE KELLAM BARRIE.KELLAM@NOTTINGHAM.AC.UK
Head of School (Professor of Medicinal Chemistry)
Aimie Garces
Professor STEPHEN HILL STEVE.HILL@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR PHARMACOLOGY
Dr NICHOLAS KINDON Nicholas.Kindon@nottingham.ac.uk
SENIOR RESEARCH FELLOW
Dr TRACEY BRADSHAW tracey.bradshaw@nottingham.ac.uk
ASSOCIATE PROFESSOR
Jin Li
Simon J.F. Macdonald
James E. Rowedder
Leigh A. Stoddart
Professor MICHAEL STOCKS MICHAEL.STOCKS@NOTTINGHAM.AC.UK
PROFESSOR OF MEDICINAL CHEMISTRY AND DRUG DISCOVERY
Abstract
A novel molecular scaffold has been synthesized, and its incorporation into new analogues of biologically active molecules across multiple target classes will be discussed. In these studies, we have shown use of the tricyclic scaffold to synthesize potent inhibitors of the serine peptidase DPP-4, antagonists of the CCR5 receptor, and highly potent and selective PI3K δ isoform inhibitors. We also describe the predicted physicochemical properties of the resulting inhibitors and conclude that the tractable molecular scaffold could have potential application in future drug discovery programs.
Citation
Schwehm, C., Kellam, B., Garces, A., Hill, S. J., Kindon, N., Bradshaw, T. D., Li, J., Macdonald, S. J., Rowedder, J. E., Stoddart, L. A., & Stocks, M. (2017). Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase-4 (DPP-4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol-3 Kinase δ (PI3Kδ) inhibitors. Journal of Medicinal Chemistry, 60(4), https://doi.org/10.1021/acs.jmedchem.6b01801
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 26, 2017 |
Publication Date | Jan 27, 2017 |
Deposit Date | Jul 11, 2017 |
Publicly Available Date | Jul 11, 2017 |
Journal | Journal of Medicinal Chemistry |
Print ISSN | 0022-2623 |
Electronic ISSN | 1520-4804 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 60 |
Issue | 4 |
DOI | https://doi.org/10.1021/acs.jmedchem.6b01801 |
Public URL | https://nottingham-repository.worktribe.com/output/838861 |
Publisher URL | http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01801 |
Contract Date | Jul 11, 2017 |
Files
acs.jmedchem.6b01801.pdf
(6.3 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
A novel and selective fluorescent ligand for the study of adenosine A2B receptors
(2024)
Journal Article
Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
(2023)
Journal Article
Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search